[VRDN] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
24-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -202.88%
YoY- -86.91%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 880 476 1,192 756 659 655 1,091 -3.51%
PBT -10,118 -10,317 -6,386 -5,570 -2,980 -2,258 -203 91.78%
Tax 50 289 77 -71 -47 0 0 -
NP -10,118 -10,317 -6,386 -5,570 -2,980 -2,258 -203 91.78%
Tax Rate - - - - - - - -
Total Cost 10,998 10,793 7,578 6,326 3,639 2,913 1,294 42.83%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -1,149.77 -2,167.44 -535.74 -736.77 -452.20 -345.00 -18.63 98.73%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -4.69 -5.02 -4.30 -7.23 -4.19 -5.85 -1.08 27.71%
EPS Diluted -4.69 -5.02 -4.30 -7.23 -4.19 -5.85 -1.08 27.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.